Skip to main content
logo
The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.210
+0.080 (2.56%)
At close: Jul 14, 2025, 4:00 PM
3.220
+0.010 (0.31%)
After-hours: Jul 14, 2025, 4:07 PM EDT

The Oncology Institute Revenue

The Oncology Institute had revenue of $104.41M in the quarter ending March 31, 2025, with 10.29% growth. This brings the company's revenue in the last twelve months to $403.15M, up 17.64% year-over-year. In the year 2024, The Oncology Institute had annual revenue of $393.41M with 21.33% growth.

Revenue (ttm)
$403.15M
Revenue Growth
+17.64%
P/S Ratio
0.59
Revenue / Employee
$488,669
Employees
825
Market Cap
290.83M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 393.41M 69.17M 21.33%
Dec 31, 2023 324.24M 71.76M 28.42%
Dec 31, 2022 252.48M 49.48M 24.37%
Dec 31, 2021 203.00M 15.49M 8.26%
Dec 31, 2020 187.52M 32.11M 20.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

TOI News

More News